Osteogenesis Imperfecta and Osteopetrosis
On this page
Direct answer
Osteogenesis imperfecta is a heritable disorder of brittle bone, most often caused by defects in type I collagen synthesis. Osteopetrosis, by contrast, is a disorder of dense but fragile bone caused by failure of osteoclast resorption. Osteogenesis imperfecta typically causes blue sclerae and dentinogenesis imperfecta, whereas osteopetrosis causes marrow failure and cranial nerve compression.
What you must remember
- Collagen defect: most cases are caused by COL1A1 or COL1A2 mutations; reduced collagen quantity gives milder disease, while structural defects give severe disease.
- Classic features: blue sclerae, dentinogenesis imperfecta, hearing loss from otosclerosis, short stature and recurrent fractures.
- Sillence classification: types I to IV, with type II being perinatally lethal.
- Osteopetrosis mechanism: failure of osteoclast resorption leads to sclerotic, dense but brittle bone.
- Marrow failure: dense bone fills the medullary cavity, causing anaemia, thrombocytopenia and extramedullary haematopoiesis.
- Cranial nerve compression: narrowed foramina cause optic atrophy, facial palsy and deafness.
- Malignant recessive form: an early and severe disease, most often from TCIRG1 mutations; carbonic anhydrase II deficiency is another cause, with renal tubular acidosis.
- Treatment: bisphosphonates reduce fracture risk in OI, while haematopoietic stem cell transplantation is the only curative option for malignant osteopetrosis.
Two children, two very different bones
Two children present with recurrent fractures, but one has blue sclerae and the other has dense bones with anaemia. The table below separates the two conditions by the defect, the bone appearance and the complications.
| Feature | Osteogenesis imperfecta | Osteopetrosis |
|---|---|---|
| Defect | Type I collagen, usually COL1A1 or COL1A2 | Osteoclast resorption, for example TCIRG1 or carbonic anhydrase II |
| Bone | Thin, osteopenic and brittle | Dense, sclerotic and still fragile |
| Eyes and teeth | Blue sclerae; dentinogenesis imperfecta | Optic atrophy from foraminal narrowing |
| Blood | Usually normal | Anaemia and pancytopenia |
| Key complication | Fractures, deformity, hearing loss | Marrow failure, cranial nerve palsies |
Radiographs of both look abnormal, but the dense bone of osteopetrosis contrasts with the thin bone of OI. Extra-skeletal features usually settle the diagnosis in an exam question. Genetic testing of COL1A1 and COL1A2 confirms OI when the clinical picture is unclear, and family history guides counselling. Hearing is checked early and repeated, since otosclerotic deafness can progress through adolescence.
Where students lose marks
These points are common traps in paediatrics and orthopaedics questions.
- Trap: thinking dense bones on X-ray always mean a healthy skeleton. Correct: in osteopetrosis the bone is dense but brittle, so it fractures easily and is prone to osteomyelitis.
- Trap: expecting blue sclerae in osteopetrosis. Correct: blue sclerae point to OI, while osteopetrosis classically shows optic and facial nerve compression.
- Trap: calling all childhood fractures non-accidental injury without considering OI. Correct: OI is an important mimic, so a skeletal survey and family history are needed before a conclusion is reached.
Frequently asked questions
What is the commonest genetic cause of osteogenesis imperfecta?
Mutations in COL1A1 or COL1A2 are the commonest cause of osteogenesis imperfecta, since both genes encode type I collagen. Dominant inheritance is most common, and severity depends on whether the defect reduces collagen quantity or disrupts its structure. Recessive forms also exist and are often more severe.
Why do patients with osteogenesis imperfecta have blue sclerae?
Blue sclerae in osteogenesis imperfecta occur because the collagen-poor sclera is thin, so the underlying choroid shows through. This reflects the same type I collagen defect that makes the bone fragile. Blue sclerae can lighten with age, but the finding remains a useful clue in childhood.
What causes marrow failure in osteopetrosis?
Marrow failure in osteopetrosis occurs because osteoclast failure leaves sclerotic bone that narrows the medullary cavity. Anaemia, thrombocytopenia and hepatosplenomegaly from extramedullary haematopoiesis are common in severe disease. Cranial nerve involvement adds to the clinical burden.
Which treatment is curative for malignant infantile osteopetrosis?
Haematopoietic stem cell transplantation is the only curative treatment for malignant infantile osteopetrosis, because donor osteoclast precursors can restore bone resorption. Interferon gamma may be used in some patients to improve osteoclast function. Supportive care for anaemia, infection and nerve compression continues alongside.